Skip to main content
Log in

Overview

Announcement
European Journal of Drug Metabolism and Pharmacokinetics invites submission of Original Research, Practical Application, Current Opinion and Review Articles on the topics of preclinical and clinical pharmacokinetics and pharmacodynamics.
Submit Now!

European Journal of Drug Metabolism and Pharmacokinetics promotes drug development by providing researchers essential information on preclinical and clinical pharmacokinetics & pharmacodynamics, including drug disposition, metabolism, transport and interactions, therapeutic drug monitoring, pharmacokinetic/pharmacodynamic relationship, bioavailability and biopharmacy.

As a hybrid journal, European Journal of Drug Metabolism and Pharmacokinetics does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘How to publish with us, including Open Access’ link below.

European Journal of Drug Metabolism and Pharmacokinetics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Editor-in-Chief
  • Jasbir Singh
Impact factor
1.9 (2022)
5 year impact factor
2.1 (2022)
Submission to first decision (median)
5 days
Downloads
186,658 (2023)

Latest articles

Journal updates

  • Digital Features

    European Journal of Drug Metabolism and Pharmacokinetics is able to host a range of digital features, with a number of options available to authors.

Journal information

Electronic ISSN
2107-0180
Print ISSN
0378-7966
Abstracted and indexed in
  1. BFI List
  2. BIOSIS
  3. Baidu
  4. Biological Abstracts
  5. CAB Abstracts
  6. CLOCKSS
  7. CNKI
  8. CNPIEC
  9. Chemical Abstracts Service (CAS)
  10. Dimensions
  11. EBSCO
  12. EMBASE
  13. Google Scholar
  14. Japanese Science and Technology Agency (JST)
  15. Medline
  16. Meta
  17. Naver
  18. OCLC WorldCat Discovery Service
  19. Pathway Studio
  20. Portico
  21. ProQuest
  22. Reaxys
  23. SCImago
  24. SCOPUS
  25. Science Citation Index Expanded (SCIE)
  26. TD Net Discovery Service
  27. UGC-CARE List (India)
  28. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG

Navigation